Combining risperidone with standard neuroleptics for refractory schizophrenic patients.
Explore the source record for details and available documents.
Antipsychotic Agents↗
Biomedical subjects
N M Bacher
Publications and source records attributed to N M Bacher.
Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
Explore the source record for details and available documents.
Adult↗
Addition of fluoxetine to treatment of schizophrenic patients.
Explore the source record for details and available documents.
Antipsychotic Agents↗
Clonazepam treatment of obsessive compulsive disorder.
Explore the source record for details and available documents.
Clonazepam↗
Possible enhancing effects of diazepam with reserpine in a chronic schizophrenic patient with tardive dyskinesia.
Explore the source record for details and available documents.
Adult↗
Cyproheptadine in movement disorders.
Explore the source record for details and available documents.
Benztropine↗
Atypical neuroleptics in mania.
Explore the source record for details and available documents.
Bipolar Disorder↗
Combined alprazolam and neuroleptic drug in treating schizophrenia.
Explore the source record for details and available documents.
Alprazolam↗
Addition of lithium to neuroleptic treatment in chronic schizophrenia.
Explore the source record for details and available documents.
Ambulatory Care↗
Verapamil and depression.
Explore the source record for details and available documents.
Bipolar Disorder↗
Reserpine and tardive dyskinesia.
Explore the source record for details and available documents.
Acute Disease↗
Abnormal dexamethasone suppression test results in schizophrenia.
Explore the source record for details and available documents.
Chronic Disease↗
Low-dose propranolol in tardive dyskinesia.
Explore the source record for details and available documents.
Antipsychotic Agents↗
Lithium plus reserpine in refractory manic patients.
The authors report on six refractory manic or schizo-affective manic male outpatients who failed to respond to lithium combined with a neuroleptic. A beneficial response was noted in most patients when reserpine was substituted for their currently prescribed standard neuroleptic; in some cases lithium dosage could then be reduced. No major side effects were encountered. The use of reserpine may offer an alternative mode of therapy for manic patients who cannot tolerate large doses of lithium or do not completely respond to lithium either alone or in combination with a standard neuroleptic.
Adult↗
Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients.
Explore the source record for details and available documents.
Adult↗